T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Alphabet (Google) Class C
GOOG
|
$5.46B |
| 2 |
Apple
AAPL
|
$4.04B |
| 3 |
AGN
ALLERGAN INC
AGN
|
$1.41B |
| 4 |
CELG
Celgene Corp
CELG
|
$1.16B |
| 5 |
American Airlines Group
AAL
|
$939M |
Top Sells
| 1 |
Procter & Gamble
PG
|
$1.36B |
| 2 |
Broadcom
AVGO
|
$813M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
$753M |
| 4 |
eBay
EBAY
|
$738M |
| 5 |
US Bancorp
USB
|
$712M |
Sector Composition
| 1 | Healthcare | 16.64% |
| 2 | Consumer Discretionary | 13.45% |
| 3 | Financials | 12.79% |
| 4 | Industrials | 12.1% |
| 5 | Technology | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Crown Castle
CCI
$43.2B
| $2.72B | 0.59% | 36,678,032 -5,773,911 | -14% | -$429M |
|
27
Johnson & Johnson
JNJ
$427B
| $2.72B | 0.59% | 26,004,474 +51,819 | +0.2% | +$5.42M |
|
|
ALXN
28
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $2.7B | 0.58% | 17,303,461 +1,829,752 | +12% | +$286M |
|
|
AGN
29
DELISTED
ALLERGAN INC
AGN
| $2.69B | 0.58% | 15,919,404 +8,326,553 | +110% | +$1.41B |
|
30
Merck
MRK
$210B
| $2.63B | 0.57% | 45,526,605 +366,002 | +0.8% | +$21.2M |
|
31
Thermo Fisher Scientific
TMO
$186B
| $2.54B | 0.55% | 21,539,155 +2,060,498 | +11% | +$243M |
|
32
Marsh & McLennan
MMC
$101B
| $2.54B | 0.55% | 48,990,485 -1,245,442 | -2% | -$64.5M |
|
33
Range Resources
RRC
$8.16B
| $2.52B | 0.55% | 29,031,513 +559,052 | +2% | +$48.6M |
|
|
AMTD
34
DELISTED
TD Ameritrade Holding Corp
AMTD
| $2.49B | 0.54% | 79,537,584 -1,555,836 | -2% | -$48.8M |
|
35
Pfizer
PFE
$141B
| $2.48B | 0.54% | 83,709,399 -21,348,962 | -20% | -$634M |
|
36
Starbucks
SBUX
$100B
| $2.48B | 0.54% | 32,043,858 +389,275 | +1% | +$30.1M |
|
37
APA Corp
APA
$8.31B
| $2.38B | 0.51% | 23,670,691 +670,477 | +3% | +$67.5M |
|
38
Morgan Stanley
MS
$240B
| $2.35B | 0.51% | 72,810,853 +22,086,294 | +44% | +$714M |
|
39
Sherwin-Williams
SHW
$91.2B
| $2.34B | 0.51% | 11,319,819 +1,109,013 | +11% | +$229M |
|
40
State Street
STT
$32.6B
| $2.31B | 0.5% | 34,372,252 -207,200 | -0.6% | -$13.9M |
|
|
CELG
41
DELISTED
Celgene Corp
CELG
| $2.29B | 0.49% | 26,649,341 +13,450,507 | +102% | +$1.16B |
|
42
American Express
AXP
$231B
| $2.28B | 0.49% | 24,051,896 -512,695 | -2% | -$48.6M |
|
43
Microsoft
MSFT
$3.77T
| $2.26B | 0.49% | 54,275,235 -5,981,574 | -10% | -$249M |
|
44
Chevron
CVX
$324B
| $2.26B | 0.49% | 17,329,464 -827,536 | -5% | -$108M |
|
45
Ecolab
ECL
$78.6B
| $2.26B | 0.49% | 20,256,912 -451,593 | -2% | -$50.3M |
|
46
Bank of America
BAC
$376B
| $2.23B | 0.48% | 145,149,433 +8,462,679 | +6% | +$130M |
|
47
Las Vegas Sands
LVS
$39.6B
| $2.17B | 0.47% | 28,471,192 -351,458 | -1% | -$26.8M |
|
48
Netflix
NFLX
$513B
| $2.16B | 0.47% | 4,901,469 +411,682 | +9% | +$181M |
|
49
Wynn Resorts
WYNN
$13.2B
| $2.1B | 0.45% | 10,095,626 +3,002,433 | +42% | +$623M |
|
50
Chipotle Mexican Grill
CMG
$56.5B
| $2.09B | 0.45% | 3,525,349 -62,559 | -2% | -$37.1M |
|